|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Apokyn (Apomorphine). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (40)
Cases resulting in a serious event (30)
Cases resulting in death (4)
Cases resulting in hospitalization (18)
Cases resulting in other serious reactions (9)
Below is a sample of reports where side effects / adverse reactions may be related to Apokyn (Apomorphine). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in 81 year old female receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-10-22
Patient: 81 year old female, weighing 42.2 kg (92.8 pounds)
Adverse reactions / side effects: Malnutrition, Anaemia, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a individual with unspecified qualification from United States on 2007-10-22
Patient: male, weighing 95.3 kg (209.6 pounds)
Adverse reactions / side effects: Dysstasia, Sciatica, Abasia, Condition Aggravated, Blood Glucose Fluctuation, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Sinemet CR; Rasagiline; Comtan; Requip; Glucophage; Actos / 01450201 /; Vytorin; Altace; Hydrochlorothiazide; Novolin / 00030501 /; Novolog; Poly-Iron / 01214501 /; Trimethobenzamide; Aspirin
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a individual with unspecified qualification from United States on 2007-10-22
Patient: male, weighing 81.2 kg (178.6 pounds)
Adverse reactions / side effects: Head Injury, Anaemia, Muscular Weakness, Ankle Fracture, Fall, Ill-Defined Disorder, Haematochezia, Impaired Healing, Disturbance in Attention, Platelet Count Decreased, Gait Disturbance
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn
Dosage: 0.2 ml bid subcutaneous
Indication: Parkinson's Disease
Start date: 2007-08-01
Apokyn
Other drugs received by patient: Depakote; Stalevo 100; Lipitor; Proscar; Lexapro; Flomax
Adverse event in 67 year old male receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-11
Patient: 67 year old male, weighing 62.6 kg (137.7 pounds)
Adverse reactions / side effects: Limb Discomfort, Incorrect Drug Administration Duration, Disease Recurrence, Pathological Gambling, Flank Pain, Hallucination, Loss of Consciousness
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-10-09
Patient: male
Adverse reactions / side effects: Death
Adverse event resulted in: death
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-01
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Pneumonia, Urinary Tract Infection, Hypotension, Pyrexia
Adverse event resulted in: death, hospitalization
Suspect drug(s):
Apokyn
Dosage: (0.3 ml subcutaneous, (0.4 ml prn subcutaneous), (0.4 ml 1x/8 hours subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-01-01
End date: 2007-07-19
Apokyn
Dosage: (0.3 ml subcutaneous, (0.4 ml prn subcutaneous), (0.4 ml 1x/8 hours subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-05-10
Apokyn
Dosage: (0.3 ml subcutaneous, (0.4 ml prn subcutaneous), (0.4 ml 1x/8 hours subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-07-21
Other drugs received by patient: Sinemet; Tigan; Comtan
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-07-30
Patient: male, weighing 68.9 kg (151.7 pounds)
Adverse reactions / side effects: Blood Pressure Systolic Decreased, Condition Aggravated, Immediate Post-Injection Reaction, Hyperhidrosis, Labile Blood Pressure, Dehydration, Dizziness, Cold Sweat, Blood Pressure Diastolic Decreased
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn
Dosage: 0.2 ml prn subcutaneous
Indication: Parkinson's Disease
Start date: 2007-07-06
Coreg
Dosage: 12.5 mg bid oral
Indication: Drug USE FOR Unknown Indication
Other drugs received by patient: Digoxin; Zocor; Comtan; Sinemet; Requip; Parcopa 10 / 100; Nexium; Tigan; Fish OIL; Garlic; Magnesium Oxide
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-07-30
Patient: female, weighing 72.1 kg (158.7 pounds)
Adverse reactions / side effects: Respiratory Rate Increased, Blood Pressure Increased, Dyspnoea, Drug Ineffective, Headache, Injection Site Bruising, Heart Rate Increased, Cold Sweat
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in 75 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-07-03
Patient: 75 year old male, weighing 77.0 kg (169.4 pounds)
Adverse reactions / side effects: Hallucination, Auditory, Hallucination, Visual, Somnambulism, Fall, Loss of Consciousness
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn
Dosage: see text (0.4 ml, 0.4 to 0.8ml)sc
Indication: Parkinson's Disease
Start date: 2005-03-12
Mirapex
Dosage: 3 mg (0.5 mg,0.5 mg 6x/day),po
Administration route: Oral
Indication: Parkinson's Disease
End date: 2006-01-01
Other drugs received by patient: Sinemet CR (Sinemet); Sinemet; Tasmar; Rifampicin; Levaquin; Klonopin; Trazodone HCL; Avodart; Cymbalta; Ketoconazole; Nexium
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-06-27
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Hallucination, Visual, Paranoia, NO Therapeutic Response, Somnolence
Suspect drug(s):
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-08
Apokyn
Dosage: 0.4 ml qd subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-09
Apokyn
Dosage: 0.3 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-10
End date: 2007-06-10
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Start date: 2007-06-11
End date: 2007-06-11
Apokyn
Dosage: 0.3 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-12
End date: 2007-06-12
Apokyn
Dosage: 0.2 ml 1x subcutaneous
Indication: Parkinson's Disease
Start date: 2007-06-13
End date: 2007-06-13
Other drugs received by patient: Effexor; Carbidopa and Levodopa; Gabapentin; Mirapex; Diclofenac; Vitamin B12 NOS; Vitamin D
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-06-27
Patient: female, weighing 61.2 kg (134.7 pounds)
Adverse reactions / side effects: Paranoia, Hallucination, Somnolence
Suspect drug(s):
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-08
Apokyn
Dosage: (0.4 ml qd subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-08
End date: 2007-06-09
Apokyn
Dosage: (0.3 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-10
End date: 2007-06-10
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-11
End date: 2007-06-11
Apokyn
Dosage: (0.3 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-12
End date: 2007-06-12
Apokyn
Dosage: (0.2 ml 1x subcutaneous)
Indication: Parkinson's Disease
Start date: 2007-06-13
End date: 2007-06-13
Other drugs received by patient: Effexor; Carbidopa and Levodopa; Vitamin B12 NOS; Mirapex; Diclofenac; Vitamin B12 NOS; Vitamin D
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-06-12
Patient: male, weighing 56.7 kg (124.7 pounds)
Adverse reactions / side effects: Hallucination, Visual, Head Injury, Transient Ischaemic Attack, Fall
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in female receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-31
Patient: female
Adverse reactions / side effects: Dyskinesia, Dizziness, Lower Limb Fracture, Headache, Fall, Hyperhidrosis
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Sinemet; Mirapex; Rasagiline
Adverse event in male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-05-24
Patient: male, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Flushing, Dyskinesia, Erythema
Suspect drug(s):
Apokyn
Dosage: subcutaneous
Indication: Parkinson's Disease
Start date: 2007-03-06
Apokyn
Dosage: 0.3 ml prn subcutaneous
Indication: Parkinson's Disease
Start date: 2007-01-01
Other drugs received by patient: Carbidopa and Levodopa; Levothyroxine Sodium; Trimethobenzamide; Rasagiline
Adverse event in 69 year old male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-05-01
Patient: 69 year old male, weighing 112.5 kg (247.5 pounds)
Adverse reactions / side effects: Vomiting, Nausea, Rhinorrhoea, Influenza
Suspect drug(s):
Apokyn
Dosage: 0.1 ml sc
Indication: Parkinson's Disease
Start date: 2007-02-16
End date: 2007-02-19
Apokyn
Dosage: 0.2 ml sc
Indication: Parkinson's Disease
Start date: 2007-02-19
End date: 2007-02-22
Other drugs received by patient: Sinemet; Requip; Atacand; Tigan
Adverse event in 77 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-05-01
Patient: 77 year old male
Adverse reactions / side effects: Dysstasia, Drooling, Communication Disorder, Orthostatic Hypotension, Lethargy
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in 81 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-05-01
Patient: 81 year old male
Adverse reactions / side effects: Blood Pressure Increased, Condition Aggravated
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Lisinopril; Propranolol; Zoloft; Sinemet
Adverse event in 65 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-05-01
Patient: 65 year old male, weighing 67.1 kg (147.7 pounds)
Adverse reactions / side effects: Myocardial Infarction
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Carbidopa and Levodopa; Seroquel; Vitamin B Complex CAP; Mirapex; Aricept
Adverse event in 58 year old female receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-01
Patient: 58 year old female, weighing 70.3 kg (154.7 pounds)
Adverse reactions / side effects: Oedema Peripheral, Hypoaesthesia
Suspect drug(s):
Apokyn
Dosage: 0.3 ml qam sc
Indication: Parkinson's Disease
Start date: 2005-07-01
Apokyn
Dosage: 0.36 ml 1xnight sc
Indication: Parkinson's Disease
Start date: 2005-07-01
Other drugs received by patient: Arimidex; Sinemet; Selegiline HCL; Comtan; Requip; Sinemet
Adverse event in 72 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-05-01
Patient: 72 year old male
Adverse reactions / side effects: Adverse Drug Reaction
Suspect drug(s):
Apokyn (Apomorphine)
Adverse event in 75 year old male receiving Apokyn (Apomorphine)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-01
Patient: 75 year old male, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Vomiting, Nausea
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Sinemet; Tigan
Adverse event in 68 year old male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-05-01
Patient: 68 year old male, weighing 72.6 kg (159.7 pounds)
Adverse reactions / side effects: Rash Maculo-Papular
Suspect drug(s):
Apokyn
Dosage: 0.4 ml once sc
Indication: Muscle Rigidity
Start date: 2006-07-31
Apokyn
Dosage: 0.4 ml once sc
Indication: Parkinson's Disease
Start date: 2006-07-31
Apokyn
Dosage: 0.2 ml qday sc
Indication: Muscle Rigidity
Start date: 2006-07-20
End date: 2006-07-31
Apokyn
Dosage: 0.2 ml qday sc
Indication: Parkinson's Disease
Start date: 2006-07-20
End date: 2006-07-31
Other drugs received by patient: Sinemet; Comtan; Remeron; Seroquel; Zanaflex; Topamax
Adverse event in 53 year old male receiving Apokyn (Apomorphine)
Reported by a consumer/non-health professional from United States on 2007-04-19
Patient: 53 year old male, weighing 54.4 kg (119.7 pounds)
Adverse reactions / side effects: Diarrhoea Haemorrhagic, Osteomyelitis
Adverse event resulted in: hospitalization
Suspect drug(s):
Apokyn (Apomorphine)
Other drugs received by patient: Carbidopa and Levodopa; Seroquel; Baclofen; Lorazepam; Protonix; Hydrocodone; Azilect; Zanaflex; Mirapex; Diphenatol; Metronidazole
Adverse event in 75 year old male receiving Apokyn (Apomorphine)
Reported by a physician from United States on 2007-04-17
Patient: 75 year old male, weighing 71.7 kg (157.7 pounds)
Adverse reactions / side effects: Blood Pressure Increased, Flushing
Suspect drug(s):
Apokyn
Dosage: 0.2 ml sc
Indication: Parkinson's Disease
Start date: 2007-03-26
End date: 2007-01-01
Apokyn
Dosage: 0.3 ml variable sc
Indication: Parkinson's Disease
Start date: 2007-01-01
Other drugs received by patient: Carbidopa and Levodopa; Levothyroxine Sodium; Trimethobenzamide; Azilect
|
